Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Mind Medicine Mindmed Inc (MNMD)

Mind Medicine Mindmed Inc (MNMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 594,467
  • Shares Outstanding, K 70,268
  • Annual Sales, $ 0 K
  • Annual Income, $ -95,730 K
  • 60-Month Beta 2.81
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 4.57
Trade MNMD with:

Options Overview Details

View History
  • Implied Volatility 106.02% ( +1.43%)
  • Historical Volatility 92.61%
  • IV Percentile 55%
  • IV Rank 31.11%
  • IV High 228.24% on 11/14/23
  • IV Low 50.83% on 10/09/23
  • Put/Call Vol Ratio 0.67
  • Today's Volume 911
  • Volume Avg (30-Day) 3,381
  • Put/Call OI Ratio 0.25
  • Today's Open Interest 50,376
  • Open Int (30-Day) 56,179

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.66
  • Number of Estimates 4
  • High Estimate -0.45
  • Low Estimate -1.18
  • Prior Year -0.51
  • Growth Rate Est. (year over year) -29.41%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.17 +4.28%
on 04/25/24
12.22 -30.28%
on 04/04/24
-1.91 (-18.31%)
since 03/25/24
3-Month
3.64 +134.07%
on 01/26/24
12.22 -30.28%
on 04/04/24
+4.87 (+133.42%)
since 01/25/24
52-Week
2.41 +253.53%
on 11/13/23
12.22 -30.28%
on 04/04/24
+4.91 (+136.01%)
since 04/25/23

Most Recent Stories

More News
This Small-Cap Stock Is Up 140% This Year and Here's Why It Can Go Even Higher

For investors with a high level of risk tolerance, Mind Medicine could be an intriguing investment option.

MNMD : 8.52 (+0.71%)
The Next Great Biotech Boom Has Arrived

EQNX::TICKER_START (NYSE:JNJ),(NASDAQ:CMPS),(NASDAQ:MNMD),(NASDAQ:ATAI),(NYSE:ABBV) EQNX::TICKER_END

JNJ : 146.82 (-1.15%)
CMPS : 7.86 (-2.96%)
MNMD : 8.52 (+0.71%)
ATAI : 1.8400 (-1.60%)
ABBV : 167.29 (-0.30%)
Up 163% YTD, Is It Too Late to Buy MindMed Stock?

Mind Medicine is a pre-revenue biopharma company that has more than doubled investor returns in 2024. Is MNMD stock a good buy today?

MNMD : 8.52 (+0.71%)
Numinus Wellness Congratulates MindMed on Positive Results from Phase 2B Clinical Trials of MM120 for Generalized Anxiety Disorder

/CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing traditional and innovative...

MNMD : 8.52 (+0.71%)
NUMIF : 0.0575 (-3.36%)
NUMI.TO : 0.0800 (unch)
This May be One of the Biggest Catalysts for Psychedelic Stocks in 2024

About 43.8 million adults in the U.S. experience a mental health issue in a given year, according to the National Institute of Mental Health (NAMI). Nearly 16 million of those adults live with major depression....

CMPS : 7.86 (-2.96%)
SEEL : 0.2856 (-5.12%)
ATAI : 1.8400 (-1.60%)
MNMD : 8.52 (+0.71%)
NUMI.TO : 0.0800 (unch)
NUMIF : 0.0575 (-3.36%)
Breaking: The US FDA Just Granted Priority Review of an MDMA Treatment for PTSD

At the moment, about 14 million people live with PTSD just in the U.S. Unfortunately, despite extensive clinical research, PTSD is still a significant unmet medical need. However, that may soon change...

CMPS : 7.86 (-2.96%)
SEEL : 0.2856 (-5.12%)
ATAI : 1.8400 (-1.60%)
MNMD : 8.52 (+0.71%)
NUMI.TO : 0.0800 (unch)
NUMIF : 0.0575 (-3.36%)
How Psychedelic-Based Therapeutics Are Advancing in Treating Generalized Anxiety Disorder (GAD) Condition

EQNX::TICKER_START (NYSE:CYBN),(NASDAQ:CMPS),(NASDAQ:MNMD),(NASDAQ:SEEL),(NASDAQ:ATAI) EQNX::TICKER_END

CYBN.NE : 0.4600 (-4.17%)
MMED.NE : 14.9000 (+9.48%)
CYBN : 0.3460 (-2.54%)
ATAI : 1.8400 (-1.60%)
MNMD : 8.52 (+0.71%)
SEEL : 0.2856 (-5.12%)
CMPS : 7.86 (-2.96%)
3 Stocks Under $10 Analysts Expect to Double

Here's a closer look at three low-priced stocks - MNMD, ASPN, and BEEM - that Wall Street is expecting to double (or more) from current levels.

MNMD : 8.52 (+0.71%)
ASPN : 15.71 (-5.59%)
BEEM : 6.43 (+1.58%)
Demand for Abuse Deterrent Formulation Technology Skyrocketing as Opiate Abuse is on the Rise

/PRNewswire/ -- The demand for abuse deterrent formulation technology is projected to grow due to growing misuse of drugs among the people. Growing demand for...

NTRBW : 0.9500 (+30.14%)
CYBN : 0.3460 (-2.54%)
NTRB : 3.65 (-5.19%)
CMND : 1.2000 (-0.83%)
MNMD : 8.52 (+0.71%)
LLY : 724.87 (-1.00%)
Demand for Abuse Deterrent Formulation Technology Skyrocketing as Opiate Abuse is on the Rise

EQNX::TICKER_START (NASDAQ:NTRB),(NASDAQ:CMND),(NASDAQ:MNMD),(NYSE:CYBN),(NYSE:LLY) EQNX::TICKER_END

NTRB : 3.65 (-5.19%)
NTRBW : 0.9500 (+30.14%)
CMND : 1.2000 (-0.83%)
MNMD : 8.52 (+0.71%)
CYBN : 0.3460 (-2.54%)
LLY : 724.87 (-1.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Mind Medicine Inc. is a clinical-stage psychedelic medicine biotech company. It discovers, develops and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. Mind Medicine Inc. is based in New York, United States.

See More

Key Turning Points

3rd Resistance Point 9.10
2nd Resistance Point 8.85
1st Resistance Point 8.68
Last Price 8.52
1st Support Level 8.26
2nd Support Level 8.01
3rd Support Level 7.84

See More

52-Week High 12.22
Last Price 8.52
Fibonacci 61.8% 8.47
Fibonacci 50% 7.32
Fibonacci 38.2% 6.16
52-Week Low 2.41

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar